Delivery Order SPE2DB22D1017-SPE2DB25FG8UE
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 25 mg capsules (100-count units) with a ceiling value of $1,129.20. The contract, which was competitively awarded without set-aside designation, was finalized on March 11, 2025, with an ultimate completion date of March 12, 2025. The firm fixed price delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Adderall XR 30 mg capsules (100-count units) valued at $3,066.16, with completion scheduled for September 16, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement running...
- The Defense Logistics Agency (DLA) awarded a competitive delivery order to AmerisourceBergen Drug Corp for Adderall XR 30 mg capsules (100-count) with a ceiling value of $1,310.42. Awarded on August 21, 2025, with an ultimate completion date of August 22, 2025, this firm fixed-price delivery order represents a routine pharmaceutical procurement under the company's existing contract vehicle with DLA. The contract carries no set-aside designation, indicating it was awarded through open...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,167.98 to AmerisourceBergen Drug Corp for the supply of Adderall XR 5 mg capsules (100-count units) under a firm fixed-price contract type. The award, made on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a non-competed delivery order with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Adderall XR 10 mg capsules (100-count) with a ceiling value of $1,104.99 under a firm fixed-price contract type. The award, issued on May 1, 2025, represents a non-competitive, non-set-aside procurement with an ultimate completion date of May 2, 2025. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which...
- The Defense Logistics Agency awarded a delivery order valued at $1,094.52 to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (100 count) on June 4, 2025, with an ultimate completion date of June 5, 2025. This firm fixed-price contract utilizes no set-aside designation and was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,431,067 units of Adderall XR 10 mg capsules. The $3,503.80 delivery order is part of a larger contract between Amerisourcebergen Drug Corp and DLA to provide pharmaceuticals and medical supplies to support military treatment programs and facilities. Amerisourcebergen Drug Corp, as a prime contractor, has extensive experience...
- This federal contract award is a delivery order valued at $1,442.85 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Adderall XR 10 mg capsules in 100-count bottles, with a completion date of November 4, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,309.38 to AmerisourceBergen Drug Corp for the supply of Adderall XR 30 mg capsules (100-count units). This non-set-aside, competitively awarded contract utilizes a firm fixed price structure and was executed on September 9, 2025, with an ultimate completion date of September 10, 2025. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a continuation of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Adderall XR 10 mg capsules (100 count) with a ceiling value of $1,990.20. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and is scheduled for completion by September 15, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG8UEDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 25 mg capsules (100-count units) with a ceiling value of $1,151.46. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at approximately $1 billion through December 2026. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of August 4, 2025. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies an extensive portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare systems. This delivery order for a neurological medication supports the Defense Logistics Agency's mission to provide comprehensive pharmaceutical support to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen's federal contract portfolio demonstrates consistent capability in fulfilling competitive federal procurement requirements across a broad spectrum of therapeutic domains, from specialty medications to vaccines and medical devices.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/1/25 |